GARP (LRRC32) is Essential for the Surface Expression of Latent TGF-B Read more about GARP (LRRC32) is Essential for the Surface Expression of Latent TGF-B US Application 61/185,933Filed on 2009-06-10
Reprogramming Of Somatic Cells By BORIS Gene Read more about Reprogramming Of Somatic Cells By BORIS Gene US Application 61/248,286Filed on 2009-10-02
Discovery Of Novel Pharmacophores Inhibiting The Growth Of Mycobacterium Tuberculosis Read more about Discovery Of Novel Pharmacophores Inhibiting The Growth Of Mycobacterium Tuberculosis US Application 61/162,588Filed on 2009-03-23
Use Of Ixolaris, A Tissue Factor (anticoagulant) Inhibitor, For The Treatment Of Cancer Read more about Use Of Ixolaris, A Tissue Factor (anticoagulant) Inhibitor, For The Treatment Of Cancer US Application 61/161,223Filed on 2009-03-18
Live Vaccine Strains of Francisella Tularensis with Defined Mutations: Composition and Method of Use Read more about Live Vaccine Strains of Francisella Tularensis with Defined Mutations: Composition and Method of Use US Application 61/156,173Filed on 2009-02-27
Influenza Hemagglutinin And Neuraminidase Variants Read more about Influenza Hemagglutinin And Neuraminidase Variants US Application 61/152,094Filed on 2009-02-12
CD121a (IL-1 Receptor Type 1) On Activated Human FOXP3+ Regulatory T Cells Read more about CD121a (IL-1 Receptor Type 1) On Activated Human FOXP3+ Regulatory T Cells US Application 61/155,430Filed on 2009-02-25
Method And Medium For Host Cell-free (axenic) Growth Of Coxiella Burnetiia Read more about Method And Medium For Host Cell-free (axenic) Growth Of Coxiella Burnetiia US Application 61/154,330Filed on 2009-02-20
Development Of Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses (TBEV/DEN4) As Vaccine Candidates For The Prevention Of Disease Caused By TBEV Read more about Development Of Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses (TBEV/DEN4) As Vaccine Candidates For The Prevention Of Disease Caused By TBEV US Application 61/181,982Filed on 2009-05-28
Synthetic HIV/SIV GAG Proteins and Uses Thereof Read more about Synthetic HIV/SIV GAG Proteins and Uses Thereof US Application 61/153,622Filed on 2009-02-18